Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


C=O bonded directly to the hetero ring (X is chalcogen)

Subclass of:

514 - Drug, bio-affecting and body treating compositions

514001000 - DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI)

514183000 - Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI

514430000 - Sulfur containing hetero ring

514438000 - The hetero ring is five-membered

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
514448000 C=O bonded directly to the hetero ring (X is chalcogen) 13
20110263692THERAPEUTIC COMPOUNDS - A compound having a structure10-27-2011
20090143461SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY - Disclosed herein are compounds having a formula:06-04-2009
20110172299THERAPEUTIC SUBSTITUTED CYCLOPENTANES - Disclosed herein are compounds represented by a formula: Therapeutic methods, compositions, and medicaments related thereto are also disclosed.07-14-2011
20090170924N-Phenethylcarboxamide Derivatives - A compound of general formula (I):07-02-2009
20110144189GUANYLHYDRAZONE COMPOUNDS, COMPOSITIONS, METHODS OF MAKING AND USING - The present invention relates to compounds having the formula:06-16-2011
20090054515SKIN-WHITENING COSMETIC - Disclosed are: a novel skin-whitening agent; and a skin-whitening cosmetic or quasi-drug which is highly effective for prevention/amelioration of melanopathy and is prepared using the skin-whitening agent. The cosmetic contains a compound represented by the general formula (I) and/or a salt thereof as an active ingredient. In the general formula (I), R02-26-2009
20090275646THERAPEUTIC COMPOUNDS - Compounds having a structure11-05-2009
20080214654Substituted Benzyloxy-Phenylmethylamide Derivatives - The present invention relates to novel substituted benzyloxy-phenylmethylamide derivatives, processes for their preparation, and their use in medicaments, especially for the prophylaxis and treatment of diseases associated with Cold Menthol Receptor 1 (CMR-1) activity, in particular for the treatment of urological diseases or disorders, such as detrusor overactivity (overactive bladder), urinary incontinence, neurogenic detrusor oeractivity (detrusor hyperflexia), idiopathic detrusor overactivity (detrusor instability), benign prostatic hyperplasia, and lower urinary tract symptoms; chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, and inflammatory disorders such as asthma and chronic obstructive pulmonary (or airways) disease (COPD).09-04-2008
20120004292COMPOSITION FOR INJECTION COMPRISING AN INJECTION MEDICINAL PRODUCT AND A GEL - A composition of an injectable medicinal product and a gel, concentrating the medicinal product on-site to reinforce its action and/or reduce the toxicity of the medicinal product.01-05-2012
20110184055THERAPEUTIC AGENTS FOR TREATMENT OF OCULAR HYPERTENSION - The invention provides well-defined amides for treating glaucoma and ocular hypertension.07-28-2011
20120178798SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY - Disclosed herein are compounds having a formula:07-12-2012
20100173981THERAPEUTIC COMPOUNDS - Disclosed herein is a compound according to one of the formulas or a pharmaceutically acceptable salt thereof, medicaments for the treatment of glaucoma or ocular hypertension and compositions related thereto, as further elaborated herein.07-08-2010
20080207741Novel Hydroxylated Aromatic Compounds - Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine08-28-2008

Patent applications in class C=O bonded directly to the hetero ring (X is chalcogen)